AHA: Lower-Target LDL Level Beneficial After Stroke, TIA
Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis
AHA: Neurohormonal Blockade Beneficial for Patients With LVAD
At four years, survival better among patients with LVADs receiving any NHB medication at six months
VA, DoD Update Guideline for Rehabilitation After Stroke
Systematic review addresses effectiveness of pharmacological, nonpharmacological interventions
CDC: ~20 Percent of U.S. Adults Currently Use Tobacco Products
Prevalence of use higher for men, adults aged ≤65 years, uninsured, those with disability or limitation
HbA1c Variability Linked to Cardiovascular Disease Risk
Risks increased for all-cause mortality, cardiovascular events, microvascular complications
AHA: Predictors for Meeting LDL-C, SBP Goals ID’d in ISCHEMIA
Older age, male sex, high-intensity statin use, lower baseline LDL-C predict LDL-C goal attainment
AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
White House Wants Hospitals, Insurers to Provide Actual Costs of Care
Government officials say the objective is to encourage competition and reduce costs
Bipartisan Bill to Curb Drug Costs Backed by White House
Senate bill does not give Medicare bargaining power but would cap out-of-pocket payments by beneficiaries
